^Stipp CS, Kolesnikova TV, Hemler ME (Oct 2001). "EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily". J Biol Chem276 (44): 40545–54. doi:10.1074/jbc.M107338200. PMID11504738.
^Clark KL, Zeng Z, Langford AL, Bowen SM, Todd SC (Oct 2001). "PGRL is a major CD81-associated protein on lymphocytes and distinguishes a new family of cell surface proteins". J Immunol167 (9): 5115–21. doi:10.4049/jimmunol.167.9.5115. PMID11673522.
Zhang XA, Lane WS, Charrin S et al. (2003). "EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.". Cancer Res.63 (10): 2665–74. PMID12750295.CS1 maint: Explicit use of et al. (link)
Bonkobara M, Das A, Takao J et al. (2003). "Identification of novel genes for secreted and membrane-anchored proteins in human keratinocytes.". Br. J. Dermatol.148 (4): 654–64. doi:10.1046/j.1365-2133.2003.05244.x. PMID12752121.CS1 maint: Explicit use of et al. (link)
Ota T, Suzuki Y, Nishikawa T et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet.36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.CS1 maint: Explicit use of et al. (link)
Kolesnikova TV, Stipp CS, Rao RM et al. (2004). "EWI-2 modulates lymphocyte integrin alpha4beta1 functions.". Blood103 (8): 3013–9. doi:10.1182/blood-2003-07-2201. PMID15070678.CS1 maint: Explicit use of et al. (link)
Yang XH, Kovalenko OV, Kolesnikova TV et al. (2006). "Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization.". J. Biol. Chem.281 (18): 12976–85. doi:10.1074/jbc.M510617200. PMID16537545.CS1 maint: Explicit use of et al. (link)
Sala-Valdés M, Ursa A, Charrin S et al. (2006). "EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins.". J. Biol. Chem.281 (28): 19665–75. doi:10.1074/jbc.M602116200. PMID16690612.CS1 maint: Explicit use of et al. (link)